In vivo efficacy of KRP-109, a novel elastase inhibitor, in a murine model of severe pneumococcal pneumonia-Reference-Cited by-同舟云学术

In vivo efficacy of KRP-109, a novel elastase inhibitor, in a murine model of severe pneumococcal pneumonia

Published:2011-12 Issue:6 Volume:24 Page:660-665
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Yamada Koichi,Yanagihara Katsunori,Araki Nobuko,Harada Yosuke,Morinaga Yoshitomo,Izumikawa Koichi,Kakeya Hiroshi,Yamamoto Yoshihiro,Hasegawa Hiroo,Kohno Shigeru,Kamihira Shimeru

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference22 articles.

1. Prospective study of the aetiology and outcome of pneumonia in the community;Woodhead;Lancet,1987

2. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain;Pallares;N Engl J Med,1995

3. Leukocyte elastase: physiological functions and role in acute lung injury;Lee;Am J Respir Crit Care Med,2001

4. ONO-5046, a novel inhibitor of human neutrophil elastase;Kawabata;Biochem Biophys Res Commun,1991

5. Delayed neutrophil proteinases of human subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters;Kawabata;Am J Respir Crit Care Med,2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking HXA ₃ -mediated neutrophil elastase release during S. pneumoniae lung infection limits pulmonary epithelial barrier disruption and bacteremia;mBio;2024-09-11

2. Blocking HXA₃-mediated neutrophil elastase release duringS. pneumoniaelung infection limits pulmonary epithelial barrier disruption and bacteremia;2024-06-25

3. The Role of Neutrophils and Neutrophil Elastase in Pneumococcal Pneumonia;Frontiers in Cellular and Infection Microbiology;2021-03-16

4. Immunomodulation in Cystic Fibrosis: Why and How?;International Journal of Molecular Sciences;2020-05-08

5. Alpha-1 Antitrypsin—A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis;International Journal of Molecular Sciences;2020-01-28